Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Humacyte financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$5.3
2024-10-29
Market Capitalization
$666.7 M
2024-10-29
Revenue
$2 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|
| Revenue | 2.0M | |||||
| Cost of goods sold | 9.7M | |||||
| Gross profit | (7.7M) | |||||
| Gross profit margin, % | -376.1% | |||||
| General and administrative expense | 21.1M | 22.9M | 23.5M | 25.8M | 31.2M | |
| Operating expense total | 329.7K | 82.5M | 86.1M | 100.0M | 114.4M | 100.5M |
| EBIT | (249.5K) | (81.2M) | (84.6M) | (100.0M) | (114.4M) | |
| Interest income | 16.0K | 2.6M | 5.5M | 4.1M | 2.6M | |
| Interest expense | 4.3M | 6.2M | 6.6M | |||
| Pre tax profit | (40.8M) | |||||
| Net Income | 1.4M | (26.5M) | (12.0M) | (110.8M) | (148.7M) | (40.8M) |
| EPS | (0.7) | (0.1) | (1.1) | (1.3) | (0.3) |